Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;4(4):e00291.
doi: 10.1002/edm2.291. Epub 2021 Jul 18.

Hyperglycaemia increases mortality risk in non-diabetic patients with COVID-19 even more than in diabetic patients

Jennifer Morse  1 , Wendy Gay  1 , Kimberly M Korwek  1 , Laura E McLean  1 , Russell E Poland  1 , Jeffrey Guy  1 , Kenneth Sands  1 , Jonathan B Perlin  1
Affiliations

Hyperglycaemia increases mortality risk in non-diabetic patients with COVID-19 even more than in diabetic patients

Jennifer Morse et al. Endocrinol Diabetes Metab. 2021 Oct.

Abstract

Aim: Diabetes has been identified as a risk factor for poor outcomes in patients with COVID-19. We examined the association of hyperglycaemia, both in the presence and absence of pre-existing diabetes, with severity and outcomes in COVID-19 patients.

Methods: Data from 74,148 COVID-19-positive inpatients with at least one recorded glucose measurement during their inpatient episode were analysed for presence of pre-existing diabetes diagnosis and any glucose values in the hyperglycaemic range (>180 mg/dl).

Results: Among patients with and without a pre-existing diabetes diagnosis on admission, mortality was substantially higher in the presence of high glucose measurements versus all measurements in the normal range (70-180 mg/dl) in both groups (non-diabetics: 21.7% vs. 3.3%; diabetics 14.4% vs. 4.3%). When adjusting for patient age, BMI, severity on admission and oxygen saturation on admission, this increased risk of mortality persisted and varied by diabetes diagnosis. Among patients with a pre-existing diabetes diagnosis, any hyperglycaemic value during the episode was associated with a substantial increase in the odds of mortality (OR: 1.77, 95% CI: 1.52-2.07); among patients without a pre-existing diabetes diagnosis, this risk nearly doubled (OR: 3.07, 95% CI: 2.79-3.37).

Conclusion: This retrospective analysis identified hyperglycaemia in COVID-19 patients as an independent risk factor for mortality after adjusting for the presence of diabetes and other known risk factors. This indicates that the extent of glucose control could serve as a mechanism for modifying the risk of COVID-19 morality in the inpatient environment.

Keywords: COVID-19; glucose variability; hyperglycaemia; inpatient glycaemic management.

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Analysis data set diagram
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention . Coronavirus Disease 2019 (COVID‐19) Cases in U.S. 2020; https://www.cdc.gov/coronavirus/2019‐ncov/cases‐updates/cases‐in‐us.html. Accessed April 22, 2020.
    1. Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid‐19 severity and fatality: a structured literature review. Infection. 2020;49(1):15‐28. - PMC - PubMed
    1. Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID‐19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(9):782‐792. - PMC - PubMed
    1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978‐982. - PubMed
    1. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798‐1807. - PMC - PubMed

Publication types